Compugen (CGEN) Shares Outstanding (Weighted Average) (2009 - 2026)

Compugen's (CGEN) quarterly Shares Outstanding (Weighted Average) came in at $94.6 million in Q1 2026, up 2.44% year-on-year from $92.3 million in Q1 2025, and up 1.21% quarter-over-quarter from $93.4 million in Q4 2025.

Compugen (CGEN) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends

Compugen has disclosed Shares Outstanding (Weighted Average) across 18 years of filings, most recently posting $94.6 million for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $94.6 million, up 2.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $94.6 million (up 2.44% YoY), and the FY2025 annual result was $93.4 million, up 4.35% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $94.6 million for Q1 2026 at Compugen, up from $93.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $94.6 million in Q1 2026 to a low of $100.0 in Q2 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $86.6 million (2022), against an average of $65.4 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) tumbled 52.38% in 2024 and surged 60.0% in 2025, its largest moves.
  • Compugen's Shares Outstanding (Weighted Average) stood at $86.6 million in 2022, then increased by 1.25% to $87.6 million in 2023, then climbed by 2.16% to $89.5 million in 2024, then rose by 4.35% to $93.4 million in 2025, then climbed by 1.21% to $94.6 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $94.6 million (Q1 2026), $93.4 million (Q4 2025), and $160.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 94.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 94.56 Mn
Dec 31, 2025 93.43 Mn
Jun 30, 2025 160.00
Mar 31, 2025 92.31 Mn
Dec 31, 2024 89.53 Mn
Jun 30, 2024 100.00
Mar 31, 2024 89.51 Mn
Dec 31, 2023 87.63 Mn
Sep 30, 2023 88.31 Mn
Jun 30, 2023 210.00
Mar 31, 2023 86.62 Mn
Dec 31, 2022 86.56 Mn
Sep 30, 2022 86.62 Mn
Jun 30, 2022 220.00
Mar 31, 2022 86.45 Mn
Dec 31, 2021 84.20 Mn
Sep 30, 2021 83.98 Mn
Jun 30, 2021 230.00
Mar 31, 2021 83.68 Mn
Dec 31, 2020 79.59 Mn